| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ba2c4156354c844d4a8883be561f00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_145bf33089a8078bbb637ed8fd5e5fcf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722bdec19abcb33038b645386153194e |
| publicationDate |
2001-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0106910-A2 |
| titleOfInvention |
VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN β2- ADRENERGIC RECEPTOR |
| abstract |
A method for predicting an individual's response to the ß-agonists salmeterol, albuterol, metaproterenol, terbutaline and formoterol is disclosed. Individuals expressing the Ile164 ß2AR variant are likely to exhibit a reduced response as compared to individuals expressing the Thr164 ß2AR variant. The method is useful for making treatment decisions for patients suffering from asthma and chronic obstructive pulmonary diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008512114-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6586183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006031181-A1 |
| priorityDate |
1999-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |